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DIETARY PHOSPHOROUS INTAKE AMONG HAEMODIALYSIS PATIENTS IN
RELATION TO DOSAGE OF PHOSPHATE BINDERS AND
HYPERPHOSPHATEMIA.
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Hyperphosphatemia in haemodialysis (HD) patients is associated with
mineral and bone disorder and increased cardiovascular disease. Despite
dietary restriction of phosphorous (P), improved dialysis therapy and
phosphate binders (PB), hyperphosphatemia remains a serious problem
among the dialysis population. A sub-optimal relationship between the
actual dietary intake of P and the intake of PB’s may be one explanation.
The aim of the present study was to investigate the dietary P intake in a
group of HD patients in relation to the taken dosage of PB, and to establish
what, if any, relationship exists with the patients’ plasma phosphate level.
Self-reported intake of P, assessed by three-day estimated food record, and
intake of PB was analysed in thirty-one adult (age 61.8712.9 years) HD
patients (17 men, 14 women), who were divided into two groups according
to their plasma P levels. The mean dietary P intake among all patients was
12707420 mg/d with a mean day-to-day variation of 3907310 mg. The P
intake in one single meal ranged from o10 mg to 1430 mg, average
2567200 mg. The variation of dosing regimens of PB among the patients
was large (1–4 to 12–16 per day), although each patient’s regimen was
ﬁxed and in most cases was 3 times daily. No signiﬁcant differences
regarding dietary P intake (p¼0.51) nor PB’s (p¼0.41) between patients
with high (41.6 mmol/l) and low (o1.6 mmol/L) plasma P levels were
observed. In conclusion, the ﬁndings show a notable individual day-to-day
and meal-to-meal variation in dietary P intake and in contradiction, the
same individual dosing regimen of PB. Strangely, no signiﬁcant difference
in the dietary P intake or intake of PBs between HD patients with high or
low plasma P level was found. The question of whether a PB intake better
tailored to the meal and day variation in P intake could prevent
hyperphosphatemia will need to be evaluated in further studies.
http://dx.doi.org/10.1016/j.krcp.2012.04.343
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IMPLEMENTING A COMPUTERISED SYSTEM WITH STANDARDISED
LANGUAGE TO ENHANCE EFFICIENCY OF NUTRITION CARE IN A
HEMODIALYSIS POPULATION
Katrina L Campbell 1,2, Megan Rossi 1,2, Maree Ferguson 1,2
1 Princess Alexandra Hospital, Brisbane, Australia
2 University of Queensland, Brisbane, Australia
To assess the impact of the implementation of an information technology
system using standardized language (International Dietetic and Nutrition
Terminology, IDNT) on efﬁciency and patient outcomes.
This was a longitudinal study of hemodialysis patients (Z18 years, Z3
months dialysis vintage) at a single facility. During the ﬁrst 6 month period
(months 0–6), patients received usual standard of care, with documentation
via a manual paper-based system. During the following 6–month period
(months 7–12), nutritional care was documented and tracked by a
computerized system incorporating IDNT. Improvement or deterioration in
nutritional status was determined via routine nutritional assessment and
documented using IDNT. Workload efﬁciency was determined using a
Workload Mapping Tool. Difference between systems was assessed using
t-test for continuous and chi-square test for categorical variables.
Ninety-one patients were recruited at baseline, another 12 patients in the
ﬁnal 6 month intervention period (age (SD) 58 years (16), 53% male (n¼55),
vintage 43 months (inter-quartile range, 25 to 75 months), malnutrition by
SGA, 10.9%). Introduction of the computerized system resulted in a higher rate
of resolution of nutritional diagnoses (mean 1.43 (CI 1.19–1.67) compared
with the paper-based system (mean 0.68 (CI 0.49–0.87)) (po0.001). The
number of patients exceeding serum phosphate targets (41.6 mmol/L)
decreased from 73% to 59% with introduction of the new system, and dry
weight change improved (mean difference 1.6% (SD 5.2) (p¼0.025)). There
was no signiﬁcant difference in malnutrition rates (p¼0.586) or inter-dialytic
ﬂuid gains (p¼0.836). Efﬁciency was improved by an average of 13 minutes
per patient per review using the new system (po0.001).
The implementation of a computerized nutrition care process incorporating




ENERGY EXPENDITURE IS INCREASED IN KIDNEY TRANSPLANT
PATIENTS.
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After kidney transplantation weight gain is associated with adverse
effects such as hypertension, dyslipidemia, insulin resistance, increased
vascular risk and deterioration of graft function. The identiﬁcation weight
gain mechanisms would be helpful to propose preventive strategies. This
study addressed energy expenditure (EE) changes after kidney
transplantation. Fifteen male patients aged 52.871.7 years, transplanted
for one to 6 years, non-diabetic and with stable renal function (calculated
creatinine clearance, 30–90 ml/min/1.73 m2) were included. They received
anticalcineurin drugs but not corticosteroids. Nine healthy volunteers
matched for age (54.271.9 years) and fat-free mass (FFM) were considered
as controls. Body composition, including FFM, was determined by DEXA. EE
was measured under controlled conditions (24 hours in calorimetric
chambers) during the following activities: sleep, rest, meals, and 2 sessions
of 30 min of treadmill walking (4 and 5 km/h). The EE results are expressed
per kg of FFM, mean 7 SEM. FFM was respectively 62.072.3 and
62.372.7 kg in patients and controls (NS). EE during sleep was 15% higher
in patients than in controls (4.3770.10 vs. 3.8070.24 kJ/hour/kg FFM,
po0.05). The 24h-EE also tended to be higher in patients compared to
controls (þ8%, p¼0.057,158.3173.90 vs. 146.1374.35 kJ/day/kg FFM). No
signiﬁcant difference was observed between patients and controls for the
EE during walking at 4 or 5 km/h, during meals and at rest.
In conclusion, in kidney transplant patient weight gain occurs despite
hyper-metabolism during sleep and over 24 h. Mechanisms of weight gain




RELATIONS BETWEEN OBESITY AND RENAL OSTEODYSTROPHY:
REGULATION OF BONE METABOLISM BY LEPTIN.
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Recently, the bone tissue is now recognized as the protagonist in the
complex control mechanism energy because their hormone interactions
with the adipose tissue. Leptin is an adipokine and its production is
proportional to the amount of adipose tissue. Although leptin is associated
with obesity, and this is recognized as the protector of bone tissue, little
can be said about the inter-relationship in chronic kidney disease. In cross-
sectional study, 32 hemodialysis patients at Botucatu Medical School -
State University of Sao Paulo - Brazil, were evaluated anthropometrically
regarding the diagnosis of metabolic syndrome (based on the
harmonization of criteria IDF, AHA/NHLBI, ATP III), biochemically and bone
biopsy. Due to variability of serum leptin was applied also values of the
natural logarithm (Ln) of leptin corrected by BMI. In comparisons was used
Kruskal-Wallis, Pearson correlations were performed using regression
analysis and considered the Ln leptin / BMI as the dependent variable was
considered signiﬁcant with p value less than 5%. Positive correlations of
leptin have been shown in females (p¼0.006), body fat percentage (po0.001),
serum albumin (p¼0.035), and markers of metabolic syndrome, such as total
cholesterol (p¼0.01) , triglycerides (p¼0.02) basal insulin (p¼0.05) and BMI
(po0.001). About renal osteodystrophy, the sample has higher prevalence
(69%) of high turnover diseases - osteitis ﬁbrosa cystica and mixed bone
disease. BMI, percent body fat, leptin and Ln leptin/BMI showed no inﬂuence on
the bone turnover and osteoporosis. In regression analysis Ln leptin/BMI was
independently associated with age (p¼0.006) and individuals diagnosed with
metabolic syndrome (p¼0.002), histological classiﬁcations of bone tissue
showed no associations. In conclusion, this was a preliminary result which
reinforced the strong and independent relationship between leptin and
metabolic syndrome in chronic renal failure, however, has not found evidence
of the relationship between obesity, leptin and bone metabolism. Therefore, we
suggest that interferes with uremia anabolic effect of leptin on the bone,
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irrespective of the very high serum levels, possibly acting on the signals in the
leptin receptor osteoblasts. Interpreting the expression of these receptors




VOLUME OVERLOAD IS ASSOCIATED WITH MALNUTRITION IN
PERITONEAL DIALYSIS
Jin Joo Cha, Young Sun Kang, Mi Jin Lee, Dae Ryong Cha
Department of Internal Medicine, Korea University Ansan Hospital
Chronic inﬂammation is one of the main causes of malnutrition in end
stage renal disease (ESRD). Volume overload is prevalent in ESRD patients,
and is associated chronic inﬂammatory process. We evaluated the
association of nutritional status with volume overload in peritoneal
dialysis patients and the long term effect of volume overload. 98 patients
were enrolled and total 78 patients completed the study. Body composition
was measured using body composition monitor (BCM,
FMC):overhydration(OH), lean tissue mass(LTM) ,fat tissue mass(ATM).
Geriatric nutritional risk index (GNRI ¼ [14.89 albumin (g/
dl)]þ[41.7body weight/ideal body weight]) were also used as a
nutritional parameter.
The patients with excess ﬂuid had lower GNRI, with less LTM and ATM at
the beginning of the study and the results remained similar after the
completion of the study. During 3-year follow up, 11 patients (14%) died.
All-cause mortality was signiﬁcantly increased in ﬂuid overload state
(unadjusted hazard ratio 1.34).
OH (0.5  1.1L) OH (1.1L  2.5L) OH (2.5L  ) p value
GNRI
0m 105.29710.9A 101.3178.42B 95.76710.51A,B 0.000
24m 105.0376.94A’ 101.9474.6B’ 98.8577.96A’,B’ 0.029
Volume overload is associated with malnutrition and seems to be an
independent predictor of mortality in PD population. Further study should
evaluate the effects of intervention of volume control in PD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.347
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NUTRITIONAL CHARACTERISTICS AND DIETARY INTAKE OF PATIENTS
ATTENDING THE PRE-DIALYSIS ASSESSMENT CLINIC
Maria Chan, John Kelly, Marijka Batterham, Linda Tapsell
The St. George Hospital and The University of Wollongong, NSW, Australia
Poor nutrition status at the start of dialysis is associated with morbidity and
mortality. Timely management of patients with ESKD pre-dialysis including
providing nutrition intervention is important. The aim of this study was to
describe the baseline nutritional status and dietary intake of patients attending
the pre-dialysis assessment clinic. Of the 210 patient assessed, 60.5% were
male; mean age was 65.7713.6 years and mean GFR was 17.074.2 ml/min.
17.1% were underweight (BMIo23 kg/m2) while 62.5% were overweight or
obese (BMI426 kg/m2). 39.5% were rated as malnourished (SGA score B&C)
and 18.5% were overweight/obese and malnourished. 26.7% had MAMC 10%
less than 50th percentile of the standard. Mean energy and protein intakes were
23.476.9 kcal/kg IBW/d and 1.1670.43 g/kg IBW/d with 65.5% and 15.6% did
not meet the recommended intake of energy and protein respectively. 48% of
patients experienced symptoms (e.g. poor appetite and nausea) affecting
dietary intake while 15.7% of patients self-imposed dietary restriction
inappropriately due to misconception of nutrition requirements in ESKD. 41.4%
and 85.2% did not consume adequate fruit and vegetables of 2 and 5 serves per
day respectively based on the Australian Guide to Healthy Eating. Nutrient
intake (prevalence %) below the Recommended Daily Intake (DRI) levels were:
VitB1 (36.5%), VitB2 (43.5%), Niacin (3.9%), VitC (202%), VitE (41.0%), folate
(83.2%), VitA (50.5%), Mg (94.5%), Fe (36.1%), Zn (70.8%) and dietary ﬁbre
(83.3%). In conclusion, patients attended the current pre-dialysis assessment
clinic presented with parameters indicative of poor nutritional health. This
clinic may provide an opportunity to optimise nutritional status of ESKD
patients before dialysis is required.
http://dx.doi.org/10.1016/j.krcp.2012.04.348
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SELF-REPORTED APPETITE AND INTAKE ADEQUACY IN PATIENTS WITH
NON-DIALYSIS CHRONIC KIDNEY DISEASE
Maria Chan, John Kelly, Marijka Batterham, Linda Tapsell
The St. George Hospital and The University of Wollongong, NSW, Australia
Subjective assessment of appetite using the Appetite and Diet Assessment
Tool (ADAT) with 5-point Likert scales, (1) very good, (2) good, (3) fair, (4) poor
and (5) very poor has been useful in screening patients for suboptimal intake
and predicting hospitalization rate in patients on maintenance dialysis. The
purpose of this study was to examine the relationships of self-reported appetite
score and the estimated energy and protein intakes in a cohort of ESKD patients
attending the pre-dialysis assessment clinic. As part of the routine assessment,
patients were asked to rate their appetite using the ADAT; their dietary intake
was assessed by the renal dietitian using a structured diet history method and
computer software analysis. Of the 205 patient assessed, 60.5%weremale;mean
age was 65.7713.6 years and mean GFR was 17.074.2 ml/min. 39.5% were
rated as malnourished (SGA score B&C). 69.8% of patients rated their appetite as
(1) very good or (2) good, whereas 30.2% rated their appetite as (3) fair or
(4) poor or (5) very poor. Intakes of 425 kcal/kg IBW/d and 40.75 g/Kg IBW/d
were considered adequate for energy and protein respectively. The mean 7SD
of energy and protein intakes rated by the appetite score are as follow:
Appetite score 1þ2 (Good) 3þ4þ5(Reduced) P value
Energy kcal/kgIBW/d 24.476.7 20.776.6 o 0.0001
Protein g/kgIBW/d 1.2170.42 1.0070.43 o 0.004
The positive predictive value (95%CI) of appetite rating for energy and
protein were 0.37 (0.32–0.41) and 0.90 (0.86–0.93) respectively. In
conclusion, while self-reported appetite scores were useful in ranking
energy and protein intakes, subjective reporting of good appetite was
associated with adequate protein but not energy intake. Report of a good
appetite does not always mean adequate intake in non-dialysis ESKD
patients with high symptom burden.
http://dx.doi.org/10.1016/j.krcp.2012.04.349
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IS OBESITY ASSOCIATED WITH ANAEMIA IN KIDNEY
TRANSPLANT RECIPIENTS
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Anaemia post renal transplantation is common and multi-factorial.
Obesity is widespread following transplantation, and is characterised by
chronic low-grade inﬂammation. Obesity-related inﬂammation may be
associated with raised hepcidin leading to anaemia by dysregulation of iron
homeostasis. This cross-sectional study aims to evaluate the associations
between obesity, inﬂammation, hepcidin and anaemia.
Ninety patients, at least 1 year post renal transplant, were recruited.
Gender: 54% male and 46% female. Mean age: 51 years. Obesity was
evaluated using Body Mass Index (BMI), Neck Circumference (NC), Waist
Circumference (WC), Waist-Hip Ratio (WHR), Triceps Skinfold Thickness
(TST), and bio-impedance measurements of Fat Tissue Index (FTI), Fat Mass
(FM) and % Body Fat (%BF). C-Reactive Protein (CRP), Albumin (Alb),
Haemoglobin (Hb), Iron (Fe), Transferrin Saturation (TSAT), and Ferritin
(Ferr) were measured by standard laboratory methods. Estimated
Glomerular Filtration Rate (eGFR) was estimated using MDRD formula.
Interleukin-6 (IL-6) was quantiﬁed by enzyme-linked immunosorbent
assay. Serum hepcidin-25 levels were determined by mass spectrometry.
Mean Hb¼12.871.9 g/dl for males, and 12.171.4 g/dl for females.
Mean eGFR¼43718 mL/min. FM correlated signiﬁcantly with CRP
(r¼0.25, po0.05). %BF correlated signiﬁcantly with IL-6 (r¼0.31, po0.05).
IL-6 correlated signiﬁcantly with hepcidin (r¼0.53, po0.01). Hepcidin
correlated signiﬁcantly with Hb (r¼0.25, po0.05), but such correlation
disappeared when adjusted for eGFR. Alb, CRP and IL-6 did not correlate
with Hb, Fe, TSAT and Ferr. Hepcidin did not correlate with Fe, TSAT, and
Ferr. BMI, NC, WC, WHR, TST, FTI, FM and %BF did not correlate with
hepcidin, Hb, Fe, TSAT and Ferr.
This study demonstrated that overall adiposity correlates positively
with inﬂammation but this is not applicable to indices of visceral fat.
However, no correlation was established between obesity and anaemia in
this study.
http://dx.doi.org/10.1016/j.krcp.2012.04.350
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